The Joint Transnational Call (JTC) 2023 has successfully concluded, selecting 13 consortia for funding, with an overall allocation of almost 17 million euros dedicated to advancing translational research on cancer epigenetics. The selected projects reflect a commitment to innovation and excellence, promising to contribute significantly to the field. The funding will support these consortia in exploring new frontiers in cancer research, potentially leading to breakthroughs in diagnosis, treatment, and prevention strategies.
The awarded projects are listed below in alphabetical order according to their acronym.
Project Acronym | Project Title |
DC2M-TAEC | Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification |
DICE | Epigenomic regulation of cancer immunity by dietary intervention |
EPI_T-ALL | Unveiling the Epigenetic Landscape and Therapeutic Implications of Epigenetic Modifiers in Human T-cell Leukemia Initiation and Progression |
EPILUCAFS | Chronic stress and immunosuppression in lung cancer: focus on epigenetic drivers in cancer-associated fibroblasts |
EPILUNAR | Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer |
EpiNanSarc | Sarcoma subtyping and stratification using genome-wide epigenetic profiling |
EPIPROPER | Identifying EPIgenetic determinants and biomarkers of drug resistance via characterization of PROspective PERsister cells |
EXPLORE-NB | Exploring the epigenetic neuroblastoma landscape to improve measurable disease monitoring, disease understanding and personalized treatment |
HYDRA | Charting the epigenomic trajectory of progression towards metastatic colorectal cancer |
REACH | Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer |
REACTION | Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk |
SCIE-PANC | Stromal Compartment and Immune Epigenome spatial networks to counter therapy evasion in PANcreatic Cancer |
SPELCASTER | Standardized Profiling of Epigenetic Loci for decentralized ClAssification of Sinonasal Tumors and idEntification of therapy Response markers |